ABCELLERA BIOLOGICS (8QQ) — Capital Reinvestment Ratio
ABCELLERA BIOLOGICS (8QQ) has a Capital Reinvestment Ratio of 0.08x as of June 2026, meaning it reinvests 0% of its operating cash flow (€25.92 Million) in capital expenditures (€2.13 Million). Check tangible equity quality of ABCELLERA BIOLOGICS to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ABCELLERA BIOLOGICS Capital Reinvestment Ratio (2021–2022)
This chart tracks ABCELLERA BIOLOGICS's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see ABCELLERA BIOLOGICS (8QQ) cash flow conversion.
Annual Capital Reinvestment Ratio for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year Capital Reinvestment Ratio for ABCELLERA BIOLOGICS from 2021 to 2022. See ABCELLERA BIOLOGICS free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.26x | €277.36 Million | €72.66 Million | ▲ +9.6% |
| 2021 | 0.24x | €244.58 Million | €58.45 Million | — |